Invention Grant
- Patent Title: Treatment of coagulation disease by administration of recombinant VWF
- Patent Title (中): 通过施用重组VWF治疗凝血疾病
-
Application No.: US13493926Application Date: 2012-06-11
-
Publication No.: US09272021B2Publication Date: 2016-03-01
- Inventor: Friedrich Scheiflinger , Peter Turecek , Bruce Ewenstein , Wing Yen Wong , Tobias M. Suiter
- Applicant: Friedrich Scheiflinger , Peter Turecek , Bruce Ewenstein , Wing Yen Wong , Tobias M. Suiter
- Applicant Address: US IL Bannockburn CH Glattpark (Opfikon)
- Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee Address: US IL Bannockburn CH Glattpark (Opfikon)
- Agency: Morgan Lewis & Bockius LLP
- Main IPC: A61K38/36
- IPC: A61K38/36 ; A61P7/02 ; A61K38/37
Abstract:
The present invention provides methods of treating coagulation disease, including hemophilia and von Willebrand disease by administering recombinant von Willebrand Factor alone or in combination with Factor VIII.
Public/Granted literature
- US20120316116A1 TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF Public/Granted day:2012-12-13
Information query
IPC分类:
